As the popularity and adoption of mobile health apps continue to grow, FDA has been working to clarify which apps are considered medical devices and how the agency plans to regulate software apps that are used on a mobile platform. Early this year FDA released a mobile medical applications guidance document.
For developers of mobile medical applications (MMA), FDA provides a variety of resources, including information on how it will exercise enforcement discretion for apps that “may” meet the definition of a medical device and examples of the MMAs cleared by FDA during the past 18 years, from the earliest digital recorders to the smartphone- and tablet-compatible AliveCor Heart Monitor.
At Device Talks Boston in May, Ronald Kurz, Sr. Director and GM at Canon Virginia, Kathryn Unger, Sr. Mgr. of Global ESG Communications at Boston Scientific, and David Ettl, COO at Gradian Health System, addressed the question, how can we…
In addition to challenges brought by new EU MDR, Switzerland has struggled to approve and introduce new devices due to its revised national medical device ordinance, which created even tougher import hurdles.
Connectivity in medical devices creates new diagnostic and treatment opportunities, yet at the same time increases the risks of cyberattacks—including their consequences for patient safety and data privacy. Now the new IEC 81001-5-1 standard provides clear technical requirements for manufacturers…
The MedTech Intelligence staff consists of freelance journalists and industry contributing writers with decades of experience in covering medical device issues under the categories of business, market trends, product development, quality, regulatory, and operations.
You can contact our writing staff via our Contact Page.